Inverness continues acquisition spree
This article was originally published in The Gray Sheet
Executive Summary
Waltham, Mass.-based Inverness Medical Innovations acquires home diagnostic services provider Quality Assured Services for $25 million in cash and stock, the companies announce June 18. The deal with the privately held Florida firm "provides Inverness with an established in-home patient service and distribution network and a leadership position in the prescription self-testing market, especially in coagulation monitoring," Inverness says. The acquisition follows Inverness agreements this year to buy heart test maker Biosite for $1.58 billion, as well as Cholestech, First Check Diagnostics and 75% of Instant Technologies (1"The Gray Sheet" June 11, 2007, p. 9)...
You may also be interested in...
Mergers & Acquisitions In Brief
Ecolab's Microtek deal focuses on infection prevention: Acquisition of Microtek Medical for $274 million is intended to expand Ecolab's infection prevention offerings, Ecolab announces Aug. 7. Microtek's surgical drapes, disposable linens, and fluid and medical waste management equipment will dovetail with Ecolab's surface disinfectants, instrument cleaning detergents and surgical hand scrubs. Microtek reported second quarter revenue of $38.5 million, up 6.8%. Ecolab, with Q2 sales of $1.4 billion (up 11%) bills itself as "the world's leading provider of cleaning, food safety and health protection products and services". Ecolab will pay $6.30 in cash for each of Microtek's 43.5 million shares outstanding - representing a 34% premium over Microtek stock's Aug. 7 closing price of $4.69...
Mergers & Acquisitions In Brief
Biomet update: The private equity group attempting to buy Biomet has increased its bid from $44 per share to $46 per share, or $10.9 billion to $11.4 billion, and has commenced a tender offer to acquire all outstanding shares. The tender offer, announced June 7 and set to begin on or before June 14, prevents the shareholder vote on the deal that had been scheduled for June 8. According to Biomet, if 75%-90% of share holders accept the tender offer within 20 business days, the deal will go to a shareholder vote. If over 90% of shareholders accept the offer, the deal will go through without a vote. The Institutional Shareholder Services released a report May 29 advising shareholders not to accept the $44 per share offer because it represented a "takeover premium" too low to justify giving up control of the company (1"The Gray Sheet" June 4, 2007, p. 4)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.